Cyclooxygenase-2 up-regulates vascular endothelial growth factor via a protein kinase C pathway in non-small cell lung cancer
2011

COX-2 and VEGF in Non-Small Cell Lung Cancer

Sample size: 84 publication Evidence: high

Author Information

Author(s): Luo Honghe, Chen Zhenguang, Jin Hui, Zhuang Mei, Wang Tao, Su Chunhua, Lei Yiyan, Zou Jianyong, Zhong Beilong

Primary Institution: The First Affiliated Hospital, Sun Yat-sen University

Hypothesis

The study aims to investigate the signaling pathway that links COX-2 with VEGF up-regulation in non-small cell lung cancer (NSCLC).

Conclusion

COX-2 may contribute to VEGF expression in NSCLC, potentially involving the PKC pathway.

Supporting Evidence

  • COX-2 over-expression correlated with microvessel density and VEGF expression in NSCLC samples.
  • Exogenously applied COX-2 stimulated the growth of NSCLC cells.
  • Inhibitors of PKC and PGE2 attenuated COX-2-induced VEGF expression in NSCLC cells.

Takeaway

This study found that a protein called COX-2 helps cancer cells make a substance called VEGF, which helps tumors grow by creating new blood vessels.

Methodology

The study used immunohistochemistry to detect COX-2 expression in NSCLC samples and assessed its association with VEGF and microvessel density.

Participant Demographics

63 male and 21 female patients with a mean age of 58 years.

Statistical Information

P-Value

P = 0.001

Confidence Interval

95% CI: 3.387 - 28.564

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1756-9966-30-6

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication